Summit Hotel Properties, Inc. (INN) News

Summit Hotel Properties, Inc. (INN): $8.64

-0.04 (-0.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add INN to Watchlist
Sign Up

Industry: REITs - Hotel


Ranked

of 17

in industry

Filter INN News Items

INN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

INN News Highlights

  • For INN, its 30 day story count is now at 5.
  • Over the past 16 days, the trend for INN's stories per day has been choppy and unclear. It has oscillated between 2 and 3.
  • The most mentioned tickers in articles about INN are API and OP.

Latest INN News From Around the Web

Below are the latest news stories about SUMMIT HOTEL PROPERTIES INC that investors may wish to consider to help them evaluate INN as an investment opportunity.

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2022 DIVIDENDS

AUSTIN, Texas, Jan. 26, 2023 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company"), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the fourth quarter ended December 31, 2022, of $0.04 per share of common…

PR Newswire | January 26, 2023

Summit Hotel Properties. – Consensus Indicates Potential 17.6% Upside

Summit Hotel Properties. with ticker code (INN) now have 5 analysts covering the stock with the consensus suggesting a rating of ''Hold''. The target price ranges between 11 and 8 with a mean TP of 9.3. With the stocks previous close at 7.91 this would indicate that there is a potential upside of 17.6%. There is a 50 day moving average of 7.81 while the 200 day moving average is 8.06. The company has a market capitalisation of $873m. Find out more information at: https://www.shpreit.com [stock_market_widget type="chart" template="basic" color="green" assets="INN" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $1,027m based on the market concensus. Summit Hotel Properties. is a publicly traded real estate investment trust focused on owning...

DirectorsTalk | January 26, 2023

SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 EARNINGS RELEASE DATE

AUSTIN, Texas , Jan. 10, 2023 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN ) (the "Company") today announced that it will report financial results for the fourth quarter and full year of 2022 on Monday, February 27, 2023 , after the market closes.

Benzinga | January 10, 2023

A stock that deserves closer examination: Summit Hotel Properties Inc. (INN)

Within its last year performance, INN fell by -26.77%, with highs and lows ranging from $10.58 to $6.57, whereas the simple moving average fell by -12.52% in the last 200 days. On September 15, 2022, CapitalOne Downgraded Summit Hotel Properties Inc. (NYSE: INN) to Equal Weight. A report published by KeyBanc Capital Markets on July […]

US Post News | January 2, 2023

Shareholders in Summit Hotel Properties (NYSE:INN) are in the red if they invested five years ago

For many, the main point of investing is to generate higher returns than the overall market. But even the best stock...

Yahoo | December 29, 2022

Innocan Pharma Signs a First Consulting Agreement to Commercialize its Pharmaceutical IP in the Veterinary Field

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - December 2, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce that it has signed a consulting agreement with Benitz Consulting LLC ("Benitz Consulting") to assist the Company's commercialization of IP in the veterinary field. The principal of Benitz Consulting

Yahoo | December 2, 2022

Innocan Pharma Reports Q3 2022 Results with 700% Increase in Revenues Compared to Q3 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a proprietary IP portfolio, is pleased to report its financial results for the three and nine months ended September 30, 2022. "We delivered encouraging results in the third quarter, with revenue growth and ar

Yahoo | November 29, 2022

Summit Hotel Properties: Confident In The 8.5% Preferred Dividend Yield (INN)

Summit Hotel Properties saw its FFO accelerated over the summer as expected. The dividend was reinstated. Read what makes INN''s current 8.5% yield appealing.

Seeking Alpha | November 18, 2022

Mr. Givi Topchishvili to Join Innocan Pharma's Advisory Committee

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 18, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a proprietary IP portfolio, is pleased to announce the addition of Givi Topchishvili, to Innocan's Advisory Committee, as a business strategy adviser, focused on commercializing of healthcare innovations. Giv

Yahoo | November 18, 2022

Glamping Goes Institutional: Summit Hotel Properties and Onera Escapes Announce Partnership with First Ever Public REIT Dedicated Glamping Investment

AUSTIN, Texas--(BUSINESS WIRE)--Summit Hotel Properties (NYSE: INN) has announced a partnership with Onera Escapes starting with the acquisition of a 90 percent joint venture interest in Onera Fredericksburg, a premium landscape hotel (glamping) asset located in Texas wine country, as well as a 90 percent interest in an adjacent land parcel for future expansion. The partnership marks the first ever standalone glamping investment from a public REIT in the fast-growing segment, which has a 14 per

Business Wire | November 17, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5953 seconds.